- IBDEI1M1 ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,298,0)
- ;;=OTHER^4^31
- ;;^UTILITY(U,$J,358.4,299,0)
- ;;=PROLONGED CLINICAL STAFF SERVICES^5^31
- ;;^UTILITY(U,$J,358.4,300,0)
- ;;=LAB TESTS^3^31
- ;;^UTILITY(U,$J,358.4,301,0)
- ;;=NEW PATIENT^3^32
- ;;^UTILITY(U,$J,358.4,302,0)
- ;;=ESTABLISHED PATIENT^2^32
- ;;^UTILITY(U,$J,358.4,303,0)
- ;;=CONSULTS - OUTPT^4^32
- ;;^UTILITY(U,$J,358.4,304,0)
- ;;=EYE CODES^1^32
- ;;^UTILITY(U,$J,358.4,305,0)
- ;;=CONSULTS - INPT^5^32
- ;;^UTILITY(U,$J,358.4,306,0)
- ;;=HOSPITAL CARE - INITIAL^6^32
- ;;^UTILITY(U,$J,358.4,307,0)
- ;;=HOSPITAL CARE - SUBSEQUENT^7^32
- ;;^UTILITY(U,$J,358.4,308,0)
- ;;=HOSPITAL CARE - DISCHARGE^8^32
- ;;^UTILITY(U,$J,358.4,309,0)
- ;;=OBSERVATION CARE - INITIAL^9^32
- ;;^UTILITY(U,$J,358.4,310,0)
- ;;=OBSERVATION CARE - SUBSEQUENT^10^32
- ;;^UTILITY(U,$J,358.4,311,0)
- ;;=OBSERVATION CARE - DISCHARGE^11^32
- ;;^UTILITY(U,$J,358.4,312,0)
- ;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^32
- ;;^UTILITY(U,$J,358.4,313,0)
- ;;=EEF Version 2022 January^13^32
- ;;^UTILITY(U,$J,358.4,314,0)
- ;;=PROC - LID / LACRIMAL^8^33
- ;;^UTILITY(U,$J,358.4,315,0)
- ;;=PROC - LASER / CRYO^11^33
- ;;^UTILITY(U,$J,358.4,316,0)
- ;;=PROC - CORNEA / CONJ^7^33
- ;;^UTILITY(U,$J,358.4,317,0)
- ;;=MEDICATIONS^13^33
- ;;^UTILITY(U,$J,358.4,318,0)
- ;;=PROC - INJECTIONS / ALL^10^33
- ;;^UTILITY(U,$J,358.4,319,0)
- ;;=IMAGE / PHOTOS^3^33
- ;;^UTILITY(U,$J,358.4,320,0)
- ;;=REFRACT / GLASSES / CL^2^33
- ;;^UTILITY(U,$J,358.4,321,0)
- ;;=TEST - CATARACT / CORNEA^5^33
- ;;^UTILITY(U,$J,358.4,322,0)
- ;;=TEST - GLAUCOMA^4^33
- ;;^UTILITY(U,$J,358.4,323,0)
- ;;=TEST - OTHER^6^33
- ;;^UTILITY(U,$J,358.4,324,0)
- ;;=EDUCATION / COUNSELING^14^33
- ;;^UTILITY(U,$J,358.4,325,0)
- ;;=EYE SURGERY CODES^12^33
- ;;^UTILITY(U,$J,358.4,326,0)
- ;;=PROC - INJECTIONS / VEGF^9^33
- ;;^UTILITY(U,$J,358.4,327,0)
- ;;=TEST - ERG / VEP^15^33
- ;;^UTILITY(U,$J,358.4,328,0)
- ;;=DIABETIC EYE EXAM^1^33
- ;;^UTILITY(U,$J,358.4,329,0)
- ;;=LOW VISION / BLINDNESS^21^34
- ;;^UTILITY(U,$J,358.4,330,0)
- ;;=RETINA - VASCULAR^12^34
- ;;^UTILITY(U,$J,358.4,331,0)
- ;;=EYELIDS / LASHES^2^34
- ;;^UTILITY(U,$J,358.4,332,0)
- ;;=NEURO / STRABISMUS^18^34
- ;;^UTILITY(U,$J,358.4,333,0)
- ;;=ORBIT - PLASTICS^20^34
- ;;^UTILITY(U,$J,358.4,334,0)
- ;;=VITREOUS^17^34
- ;;^UTILITY(U,$J,358.4,335,0)
- ;;=ORBIT - TRAUMA^19^34
- ;;^UTILITY(U,$J,358.4,336,0)
- ;;=LACRIMAL / NLD / NEOPLASMS^3^34
- ;;^UTILITY(U,$J,358.4,337,0)
- ;;=MOST FREQUENT^1^34
- ;;^UTILITY(U,$J,358.4,338,0)
- ;;=CONJUNCTIVA / SCLERA^4^34
- ;;^UTILITY(U,$J,358.4,339,0)
- ;;=CORNEA / ULCER^5^34
- ;;^UTILITY(U,$J,358.4,340,0)
- ;;=LENS / CATARACT / POSTOP^6^34
- ;;^UTILITY(U,$J,358.4,341,0)
- ;;=IRIS / UVEITIS^7^34
- ;;^UTILITY(U,$J,358.4,342,0)
- ;;=GLAUCOMA - OPEN ANGLE^8^34
- ;;^UTILITY(U,$J,358.4,343,0)
- ;;=GLAUCOMA - CLOSED ANGLE^9^34
- ;;^UTILITY(U,$J,358.4,344,0)
- ;;=GLAUCOMA - SECONDARY^10^34
- ;;^UTILITY(U,$J,358.4,345,0)
- ;;=RETINA - CHOROID / TUMORS / INFLAM^14^34
- ;;^UTILITY(U,$J,358.4,346,0)
- ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^34
- ;;^UTILITY(U,$J,358.4,347,0)
- ;;=RETINA - MACULA^11^34
- ;;^UTILITY(U,$J,358.4,348,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^23^34
- ;;^UTILITY(U,$J,358.4,349,0)
- ;;=PMH / OTHER^22^34
- ;;^UTILITY(U,$J,358.4,350,0)
- ;;=RETINA - VEGF INJECT DX CODES^16^34
- ;;^UTILITY(U,$J,358.4,351,0)
- ;;=RETINA - DIABETIC RETINOPATHY^13^34
- ;;^UTILITY(U,$J,358.4,352,0)
- ;;=NEW PATIENT^2^35
- ;;^UTILITY(U,$J,358.4,353,0)
- ;;=ESTABLISHED PATIENT^1^35
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1M1 3744 printed Feb 18, 2025@23:37:42 Page 2
- IBDEI1M1 ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,298,0)
- +2 ;;=OTHER^4^31
- +3 ;;^UTILITY(U,$J,358.4,299,0)
- +4 ;;=PROLONGED CLINICAL STAFF SERVICES^5^31
- +5 ;;^UTILITY(U,$J,358.4,300,0)
- +6 ;;=LAB TESTS^3^31
- +7 ;;^UTILITY(U,$J,358.4,301,0)
- +8 ;;=NEW PATIENT^3^32
- +9 ;;^UTILITY(U,$J,358.4,302,0)
- +10 ;;=ESTABLISHED PATIENT^2^32
- +11 ;;^UTILITY(U,$J,358.4,303,0)
- +12 ;;=CONSULTS - OUTPT^4^32
- +13 ;;^UTILITY(U,$J,358.4,304,0)
- +14 ;;=EYE CODES^1^32
- +15 ;;^UTILITY(U,$J,358.4,305,0)
- +16 ;;=CONSULTS - INPT^5^32
- +17 ;;^UTILITY(U,$J,358.4,306,0)
- +18 ;;=HOSPITAL CARE - INITIAL^6^32
- +19 ;;^UTILITY(U,$J,358.4,307,0)
- +20 ;;=HOSPITAL CARE - SUBSEQUENT^7^32
- +21 ;;^UTILITY(U,$J,358.4,308,0)
- +22 ;;=HOSPITAL CARE - DISCHARGE^8^32
- +23 ;;^UTILITY(U,$J,358.4,309,0)
- +24 ;;=OBSERVATION CARE - INITIAL^9^32
- +25 ;;^UTILITY(U,$J,358.4,310,0)
- +26 ;;=OBSERVATION CARE - SUBSEQUENT^10^32
- +27 ;;^UTILITY(U,$J,358.4,311,0)
- +28 ;;=OBSERVATION CARE - DISCHARGE^11^32
- +29 ;;^UTILITY(U,$J,358.4,312,0)
- +30 ;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^32
- +31 ;;^UTILITY(U,$J,358.4,313,0)
- +32 ;;=EEF Version 2022 January^13^32
- +33 ;;^UTILITY(U,$J,358.4,314,0)
- +34 ;;=PROC - LID / LACRIMAL^8^33
- +35 ;;^UTILITY(U,$J,358.4,315,0)
- +36 ;;=PROC - LASER / CRYO^11^33
- +37 ;;^UTILITY(U,$J,358.4,316,0)
- +38 ;;=PROC - CORNEA / CONJ^7^33
- +39 ;;^UTILITY(U,$J,358.4,317,0)
- +40 ;;=MEDICATIONS^13^33
- +41 ;;^UTILITY(U,$J,358.4,318,0)
- +42 ;;=PROC - INJECTIONS / ALL^10^33
- +43 ;;^UTILITY(U,$J,358.4,319,0)
- +44 ;;=IMAGE / PHOTOS^3^33
- +45 ;;^UTILITY(U,$J,358.4,320,0)
- +46 ;;=REFRACT / GLASSES / CL^2^33
- +47 ;;^UTILITY(U,$J,358.4,321,0)
- +48 ;;=TEST - CATARACT / CORNEA^5^33
- +49 ;;^UTILITY(U,$J,358.4,322,0)
- +50 ;;=TEST - GLAUCOMA^4^33
- +51 ;;^UTILITY(U,$J,358.4,323,0)
- +52 ;;=TEST - OTHER^6^33
- +53 ;;^UTILITY(U,$J,358.4,324,0)
- +54 ;;=EDUCATION / COUNSELING^14^33
- +55 ;;^UTILITY(U,$J,358.4,325,0)
- +56 ;;=EYE SURGERY CODES^12^33
- +57 ;;^UTILITY(U,$J,358.4,326,0)
- +58 ;;=PROC - INJECTIONS / VEGF^9^33
- +59 ;;^UTILITY(U,$J,358.4,327,0)
- +60 ;;=TEST - ERG / VEP^15^33
- +61 ;;^UTILITY(U,$J,358.4,328,0)
- +62 ;;=DIABETIC EYE EXAM^1^33
- +63 ;;^UTILITY(U,$J,358.4,329,0)
- +64 ;;=LOW VISION / BLINDNESS^21^34
- +65 ;;^UTILITY(U,$J,358.4,330,0)
- +66 ;;=RETINA - VASCULAR^12^34
- +67 ;;^UTILITY(U,$J,358.4,331,0)
- +68 ;;=EYELIDS / LASHES^2^34
- +69 ;;^UTILITY(U,$J,358.4,332,0)
- +70 ;;=NEURO / STRABISMUS^18^34
- +71 ;;^UTILITY(U,$J,358.4,333,0)
- +72 ;;=ORBIT - PLASTICS^20^34
- +73 ;;^UTILITY(U,$J,358.4,334,0)
- +74 ;;=VITREOUS^17^34
- +75 ;;^UTILITY(U,$J,358.4,335,0)
- +76 ;;=ORBIT - TRAUMA^19^34
- +77 ;;^UTILITY(U,$J,358.4,336,0)
- +78 ;;=LACRIMAL / NLD / NEOPLASMS^3^34
- +79 ;;^UTILITY(U,$J,358.4,337,0)
- +80 ;;=MOST FREQUENT^1^34
- +81 ;;^UTILITY(U,$J,358.4,338,0)
- +82 ;;=CONJUNCTIVA / SCLERA^4^34
- +83 ;;^UTILITY(U,$J,358.4,339,0)
- +84 ;;=CORNEA / ULCER^5^34
- +85 ;;^UTILITY(U,$J,358.4,340,0)
- +86 ;;=LENS / CATARACT / POSTOP^6^34
- +87 ;;^UTILITY(U,$J,358.4,341,0)
- +88 ;;=IRIS / UVEITIS^7^34
- +89 ;;^UTILITY(U,$J,358.4,342,0)
- +90 ;;=GLAUCOMA - OPEN ANGLE^8^34
- +91 ;;^UTILITY(U,$J,358.4,343,0)
- +92 ;;=GLAUCOMA - CLOSED ANGLE^9^34
- +93 ;;^UTILITY(U,$J,358.4,344,0)
- +94 ;;=GLAUCOMA - SECONDARY^10^34
- +95 ;;^UTILITY(U,$J,358.4,345,0)
- +96 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^34
- +97 ;;^UTILITY(U,$J,358.4,346,0)
- +98 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^34
- +99 ;;^UTILITY(U,$J,358.4,347,0)
- +100 ;;=RETINA - MACULA^11^34
- +101 ;;^UTILITY(U,$J,358.4,348,0)
- +102 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^34
- +103 ;;^UTILITY(U,$J,358.4,349,0)
- +104 ;;=PMH / OTHER^22^34
- +105 ;;^UTILITY(U,$J,358.4,350,0)
- +106 ;;=RETINA - VEGF INJECT DX CODES^16^34
- +107 ;;^UTILITY(U,$J,358.4,351,0)
- +108 ;;=RETINA - DIABETIC RETINOPATHY^13^34
- +109 ;;^UTILITY(U,$J,358.4,352,0)
- +110 ;;=NEW PATIENT^2^35
- +111 ;;^UTILITY(U,$J,358.4,353,0)
- +112 ;;=ESTABLISHED PATIENT^1^35
